Categoría: muscular dystrophy
-
Neil Riordan Talks Stem Cells on Larry North’s “Better You Show”
—
por
en Autism, Bone Marrow Stem Cells, Cerebral Palsy, COPD, Dallas-Forth Worth, Duchenne’s muscular dystrophy, Heart Failure, Hip, Knee, Mesenchymal Stem Cells, Multiple Sclerosis, muscular dystrophy, Neil Riordan PA PhD, News, Orthopedics, Osteoarthritis, Rheumatoid Arthritis, Spinal Cord Injury, Sports Injuries, Stem Cell Institute Panama, Stem Cell Therapy, Texas, umbilical cord tissue stem cellsLarry North has been helping people become healthy for over 25 years. He’s done this with three best-selling books, seminars, gyms, and his radio show. Larry sat down with Neil Riordan, PA, PhD, and chairman of MedStem Panama to discuss stem cells. Dr. Riordan has also published many scientific articles in peer-reviewed journals. This…
-
US FDA Green Lights Second Duchenne’s Muscular Dystrophy Patient To Receive Human Umbilical Cord Stem Cells In US
(PRWEB) MAY 26, 2016 After several promising treatments in Panama using stem cell technology developed by Medistem Panama Inc. at the City of Knowledge in Panama, a 6 year-old Duchenne’s muscular dystrophy patient received his first umbilical cord tissue-derived mesenchymal stem cells in the US earlier this year following FDA approval of a second application…
-
Why Stem Cells Work: Clinical Trials for Spinal Cord Injury, Multiple Sclerosis, Rheumatoid Arthritis, and Duchenne’s Muscular Dystrophy
—
por
en Bone Marrow Stem Cells, Clinical Trials, Duchenne’s muscular dystrophy, Duchenne’s muscular dystrophy, Medistem Labs Panama, Mesenchymal Stem Cells, Multiple Sclerosis, muscular dystrophy, Muscular Dystrophy, Neil Riordan PA PhD, News, Rheumatoid Arthritis, Spinal Cord Injury, Stem Cell Lecture Videos, Stem Cell Research, Stem Cell Therapy, umbilical cord tissue stem cellsNeil Riordan, PhD speaks at the Riordan-McKenna Institute and Stem Cell Institute fall seminar in Southlake, Texas on October 10, 2015. Dr. Riordan discusses: How our lab selects uses specialized screening techniques to select only the stem cells that we know will be the most useful for our patients. Only about 1 in 100 cords…